Israel · Delayed Price · Currency is ILS · Price in ILA Ilex Medical Statistics
Total Valuation
Ilex Medical has a market cap or net worth of ILS 672.63 million. The enterprise value is 487.59 million.
| Market Cap | 672.63M |
| Enterprise Value | 487.59M |
Important Dates
The last earnings date was Friday, April 3, 2026.
| Earnings Date | Apr 3, 2026 |
| Ex-Dividend Date | Apr 10, 2026 |
Share Statistics
Ilex Medical has 11.19 million shares outstanding. The number of shares has increased by 0.08% in one year.
| Current Share Class | 11.19M |
| Shares Outstanding | 11.19M |
| Shares Change (YoY) | +0.08% |
| Shares Change (QoQ) | -0.49% |
| Owned by Insiders (%) | 62.77% |
| Owned by Institutions (%) | 11.83% |
| Float | 2.84M |
Valuation Ratios
The trailing PE ratio is 12.10.
| PE Ratio | 12.10 |
| Forward PE | n/a |
| PS Ratio | 0.72 |
| PB Ratio | 0.98 |
| P/TBV Ratio | 1.01 |
| P/FCF Ratio | 14.66 |
| P/OCF Ratio | 9.23 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 4.76, with an EV/FCF ratio of 10.63.
| EV / Earnings | 8.78 |
| EV / Sales | 0.52 |
| EV / EBITDA | 4.76 |
| EV / EBIT | 9.22 |
| EV / FCF | 10.63 |
Financial Position
The company has a current ratio of 2.83, with a Debt / Equity ratio of 0.07.
| Current Ratio | 2.83 |
| Quick Ratio | 1.98 |
| Debt / Equity | 0.07 |
| Debt / EBITDA | 0.41 |
| Debt / FCF | 1.02 |
| Interest Coverage | 15.74 |
Financial Efficiency
Return on equity (ROE) is 8.35% and return on invested capital (ROIC) is 9.73%.
| Return on Equity (ROE) | 8.35% |
| Return on Assets (ROA) | 3.99% |
| Return on Invested Capital (ROIC) | 9.73% |
| Return on Capital Employed (ROCE) | 8.61% |
| Weighted Average Cost of Capital (WACC) | 3.85% |
| Revenue Per Employee | 5.23M |
| Profits Per Employee | 312,107 |
| Employee Count | 178 |
| Asset Turnover | 0.94 |
| Inventory Turnover | 4.08 |
Taxes
In the past 12 months, Ilex Medical has paid 18.58 million in taxes.
| Income Tax | 18.58M |
| Effective Tax Rate | 25.06% |
Stock Price Statistics
The stock price has decreased by -1.92% in the last 52 weeks. The beta is -0.11, so Ilex Medical's price volatility has been lower than the market average.
| Beta (5Y) | -0.11 |
| 52-Week Price Change | -1.92% |
| 50-Day Moving Average | 6,043.98 |
| 200-Day Moving Average | 6,296.71 |
| Relative Strength Index (RSI) | 51.91 |
| Average Volume (20 Days) | 2,072 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Ilex Medical had revenue of ILS 930.83 million and earned 55.56 million in profits. Earnings per share was 4.97.
| Revenue | 930.83M |
| Gross Profit | 211.88M |
| Operating Income | 63.50M |
| Pretax Income | 74.14M |
| Net Income | 55.56M |
| EBITDA | 113.00M |
| EBIT | 63.50M |
| Earnings Per Share (EPS) | 4.97 |
Balance Sheet
The company has 231.64 million in cash and 46.60 million in debt, with a net cash position of 185.04 million or 16.54 per share.
| Cash & Cash Equivalents | 231.64M |
| Total Debt | 46.60M |
| Net Cash | 185.04M |
| Net Cash Per Share | 16.54 |
| Equity (Book Value) | 684.71M |
| Book Value Per Share | 61.37 |
| Working Capital | 468.27M |
Cash Flow
In the last 12 months, operating cash flow was 72.87 million and capital expenditures -26.98 million, giving a free cash flow of 45.89 million.
| Operating Cash Flow | 72.87M |
| Capital Expenditures | -26.98M |
| Depreciation & Amortization | 49.50M |
| Net Borrowing | -13.68M |
| Free Cash Flow | 45.89M |
| FCF Per Share | 4.10 |
Margins
Gross margin is 22.76%, with operating and profit margins of 6.82% and 5.97%.
| Gross Margin | 22.76% |
| Operating Margin | 6.82% |
| Pretax Margin | 7.96% |
| Profit Margin | 5.97% |
| EBITDA Margin | 12.14% |
| EBIT Margin | 6.82% |
| FCF Margin | 4.93% |
Dividends & Yields
This stock pays an annual dividend of 1.22, which amounts to a dividend yield of 2.03%.
| Dividend Per Share | 1.22 |
| Dividend Yield | 2.03% |
| Dividend Growth (YoY) | 62.87% |
| Years of Dividend Growth | n/a |
| Payout Ratio | 24.56% |
| Buyback Yield | -0.08% |
| Shareholder Yield | 1.95% |
| Earnings Yield | 8.26% |
| FCF Yield | 6.82% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on August 21, 2000. It was a forward split with a ratio of 9.
| Last Split Date | Aug 21, 2000 |
| Split Type | Forward |
| Split Ratio | 9 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 4 |